Trade LEXX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Lexaria Bioscience Corp. (LEXX) is trading at US$3.43, up 5.71% today as of Sep 21, 16:00 EDT. The company has a market capitalisation of US$18.04M. Over the past 52 weeks, LEXX has traded between US$0.35 and US$14.37. On Syfe you can trade LEXX with $0 commission and add it to your watchlist.
| Previous close | US$3.24 |
|---|---|
| Market cap | US$18.04M |
| 52-week range | US$0.35 – US$14.37 |
| Volume | 25.96K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Lexaria Bioscience Corp.
Lexaria Bioscience Corp. is a biotechnology company, which engages in the provision of active pharmaceutical ingredients through its DehydraTECH drug delivery technology. It operates through the IP licensing segment which generates revenue from customers by licensing its proprietary DehydraTECH technology. The company was founded on December 9, 2004 and is headquartered in Kelowna, Canada.
Year: 2006
Lexaria Bioscience Corp. (LEXX) stock is trading at US$3.43, +5.71% from the previous close of US$3.24.
The market cap for Lexaria Bioscience Corp. (LEXX) stock is approximately US$18.04M.
The 52-week high for Lexaria Bioscience Corp. (LEXX) stock is US$14.37.
The 52-week low for Lexaria Bioscience Corp. (LEXX) stock is US$0.35.
Lexaria Bioscience Corp. (LEXX) does not currently pay a dividend.
Stay on top of LEXX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
